BSE: STAR - Strides Pharma Science Limited

Yield per half year: -27.91%

Share chart Strides Pharma Science Limited

Extended chart Simple chart
Financial Markets by TradingView

About

Strides Pharma Science Limited develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, India, and internationally. It operates through two segments, Pharmaceutical and Biopharmaceutical. The company offers pharma generics in various forms, such as tablets, hard and soft gelatin capsules, sachets, and liquids, as well as nasal spray, gels, powders, solids, ointments, and creams.

more details
It also develops branded generics products for the treatment of chronic therapies, including women's health, central nervous system, cardiovascular, diabetes, dermatology, and probiotics under the Renerve, Unibrol, Combiart, Duotab, and Vitafer brands; and anti-retroviral, anti-malarial, anti-tuberculosis, Hepatitis, and other infectious disease drug segments for institutional business. The company was formerly known as Strides Shasun Limited and changed its name to Strides Pharma Science Limited in July 2018. Strides Pharma Science Limited was incorporated in 1990 and is headquartered in Bengaluru, India.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

EBITDA 3.77
EV/EBITDA 12.02
ISIN INE939A01011
Industry Pharmaceuticals
P/BV 1.06
P/E 75.66
P/S 1.02
Sector Health Care
Валюта inr
Валюта отчета inr
Выручка 27.07
Див.доход ао 0
Дивиденд ао 1.5
Сайт https://www.strides.com
Цена ао 1324.6
Число акций ао 0.0903 млрд
Change price per day: +0.4362% (676.3)
Change price per week: -0.738% (684.3)
Change price per month: -55.54% (1527.7)
Change price per 3 month: -51.81% (1409.6)
Change price per half year: -27.91% (942.2)
Change price per year: +5.8% (642)
Change price per 3 year: +62.44% (418.15)
Change price per 5 year: +75.79% (386.4)
Change price per 10 year: 0% (679.25)
Change price per year to date: -1.6% (690.3)
All parameters

Underestimation

Title Value Grade
P/S 1.76 8
P/BV 3.44 5
P/E 0 0
EV/EBITDA 22.91 5
Total: 5.5

Efficiency

Title Value Grade
ROA, % -1.13 0
ROE, % -3.26 0
Total: 0.6667

Dividends

Title Value Grade
Div yield, % 0.0512 0.13
DSI 0.8571 8.57
Total: 1.79

Debt

Title Value Grade
Debt/EBITDA 11.07 0
Total: 5.8

Growth impulse

Title Value Grade
Yield Revenue, % 49.63 6
Yield Ebitda, % -46.65 0
Yield EPS, % -289.02 0
Total: 3.2
More

Head Job title Payment Year of birth
Mr. Arun Kumar Pillai B.Com. Founder & Executive Chairperson 60M 1961 (64 years)
Mr. Badree Komandur MD & Group CEO 44M 1972 (53 years)
Ms. Manjula Ramamurthy Compliance Officer & Company Secretary N/A
Sormistha Ghosh Group General Counsel, Chief Risk Officer & Chief Sustainability Officer N/A
Mr. C. K. Sundar Executive Vice President of Operations N/A
Mr. Kevin P. Cook Senior Vice President of Strides Pharma Inc. N/A
Mr. P. V. S. Ramaraju Chief Operating Officer N/A
Mr. Aditya Arun Kumar Executive Director of Business Development & Director
Mr. Vikesh Kumar Group CFO & Chief Investor Relations Officer 1985 (40 years)
Ms. Surabhi Loshali Group Chief Human Resource Officer 1980 (45 years)

Address: India, Bengaluru, Strides House - open in Google maps, open in Yandex maps
Website: https://www.strides.com